Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Oldenburg

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
European Urology|August 23, 2015
Guidelines on Testicular Cancer: 2015 UpdatePeter Albers, Walter Albrecht, Ferran Algaba, et al.
Journal of the National Cancer Institute|November 27, 2009
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivorsMarianne Brydøy, Jan Oldenburg, Olbjørn Klepp, et al.
Oncotarget|September 12, 2022
Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitorsAndliena Tahiri, Katarina Puco, Faris Naji, et al.
Psycho-Oncology|October 16, 2008
Fear of recurrence in long-term testicular cancer survivorsTone Skaali, Sophie D Fosså, Roy Bremnes, et al.
Anticancer Research|March 10, 2015
Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up studyLine V Hjelle, Per O M Gundersen, Jan Oldenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-upHege S Haugnes, George J Bosl, Hink Boer, et al.
European Urology|November 5, 2017
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines PanelJoost L Boormans, Javier Mayor de Castro, Lorenzo Marconi, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cellsMirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, et al.
European Urology Open Science|September 15, 2022
Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative ReviewErnest Kaufmann, Luca Antonelli, Peter Albers, et al.
Urologic Oncology|August 16, 2016
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivorsLine V Hjelle, Roy M Bremnes, Per O M Gundersen, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
European Urology|August 23, 2015
Guidelines on Testicular Cancer: 2015 UpdatePeter Albers, Walter Albrecht, Ferran Algaba, et al.
Journal of the National Cancer Institute|November 27, 2009
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivorsMarianne Brydøy, Jan Oldenburg, Olbjørn Klepp, et al.
Oncotarget|September 12, 2022
Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitorsAndliena Tahiri, Katarina Puco, Faris Naji, et al.
Psycho-Oncology|October 16, 2008
Fear of recurrence in long-term testicular cancer survivorsTone Skaali, Sophie D Fosså, Roy Bremnes, et al.
Anticancer Research|March 10, 2015
Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up studyLine V Hjelle, Per O M Gundersen, Jan Oldenburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2012
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-upHege S Haugnes, George J Bosl, Hink Boer, et al.
European Urology|November 5, 2017
Testicular Tumour Size and Rete Testis Invasion as Prognostic Factors for the Risk of Relapse of Clinical Stage I Seminoma Testis Patients Under Surveillance: a Systematic Review by the Testicular Cancer Guidelines PanelJoost L Boormans, Javier Mayor de Castro, Lorenzo Marconi, et al.
Journal of Cancer Research and Clinical Oncology|July 18, 2016
Cabazitaxel overcomes cisplatin resistance in germ cell tumour cellsMirjam Gerwing, Christine Jacobsen, Sergey Dyshlovoy, et al.
European Urology Open Science|September 15, 2022
Oncological Follow-up Strategies for Testicular Germ Cell Tumours: A Narrative ReviewErnest Kaufmann, Luca Antonelli, Peter Albers, et al.
Urologic Oncology|August 16, 2016
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivorsLine V Hjelle, Roy M Bremnes, Per O M Gundersen, et al.
Pageof 10